Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
TheraSyn Sensors is a biotechnology company specializing in the development of next-generation biosensors powered by synthetic biology. The company's platform utilizes engineered biological components, such as gene circuits and proteins, to detect and quantify specific metabolic markers and pathogens with high precision. Their primary focus includes continuous monitoring solutions for chronic conditions such as diabetes and real-time diagnostics for acute clinical settings. By integrating biological sensing with electronic interfaces, TheraSyn aims to provide actionable health data through minimally invasive or wearable devices. The company's technology represents a significant shift from traditional electrochemical sensors to highly specific biological recognition systems.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on TheraSyn Sensors.